Jefferies Maintains a 'Hold' on BioMed Realty (BMR); Q2 Review: Signs of Life
Tweet
Share
E-mailGet Alerts BMR Hot Sheet
Price: $1.28 --0%
Rating Summary:
6 Buy, 8 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 15 | New: 40
Rating Summary:
6 Buy, 8 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 15 | New: 40
Join SI Premium – FREE
Jefferies maintains a 'Hold' on BioMed Realty (NYSE: BMR) price target of $22.00 (from $23.00).
Analyst, Omotayo Okusanya, said, "We maintain our rating on BMR stock given that 1) fundamentals continue to improve (i.e. same-store cash NOI growth increased in 2Q12 to +6.4%, with same-store leased percentage also up 460 bps year-over-year to 85.9%) and 2) BMR continues to put capital to work accretively via attractive investments."
FY EPS estimate lowered from $1.45 to $1.39.
For an analyst ratings summary and ratings history on BioMed Realty click here. For more ratings news on BioMed Realty click here.
Shares of BioMed Realty closed at $18.50 yesterday.
Analyst, Omotayo Okusanya, said, "We maintain our rating on BMR stock given that 1) fundamentals continue to improve (i.e. same-store cash NOI growth increased in 2Q12 to +6.4%, with same-store leased percentage also up 460 bps year-over-year to 85.9%) and 2) BMR continues to put capital to work accretively via attractive investments."
FY EPS estimate lowered from $1.45 to $1.39.
For an analyst ratings summary and ratings history on BioMed Realty click here. For more ratings news on BioMed Realty click here.
Shares of BioMed Realty closed at $18.50 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Unicycive Therapeutics (UNCY) PT Raised to $15 at Benchmark Following Q2 Results
- GLJ Research Downgrades Fluence Energy Inc. (FLNC) to Hold
- Freedom Broker Upgrades Taylor Devices, Inc. (TAYD) to Buy
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT ChangeRelated Entities
Jefferies & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
